WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2020> 26> 2

Volume: 26 Issue: 2

1. Limited expression of toll-like receptor 9 on T cells andits functional consequences in patients with nonalcoholicfatty liver disease Page:240—241
2. Intricate interpretation of etiology-specific outcomecomparison in patients with hepatocellular carcinoma Page:238—239
3. Does limited expression of toll-like receptor 9 actuallycontribute to T cell activation and liver damage in nonalcoholicsteatohepatitis? Page:236—237
4. A challenge in distinguishing between acute hepatitis Band acute exacerbation of chronic hepatitis B Page:233—235
5. Fibrolamellar hepatocellular carcinoma-related hyperammonemicencephalopathy: Up to now and next steps Page:231—232
6. Multimodal sequential treatment for occluded TIPS:Case report and review of literature Page:227—230
7. Limited expression of TLR9 on T cells and its functionalconsequences in patients with nonalcoholic fatty liverdisease Page:216—226
8. Trends in the prevalence of chronic liver disease in theKorean adult population, 1998–2017 Page:209—215
9. Comparisons between non-alcoholic steatohepatitisand alcohol-related hepatocellular carcinoma Page:196—208
10. The dilemma of differentiating between acute hepatitisB and chronic hepatitis B with acute exacerbation: Isquantitative serology the answer? Page:187—195
11. Toll-like receptor 9, a possible blocker of non-alcoholicsteatohepatitis? Page:185—186
12. Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease? Page:183—184
13. Should physicians go out of the way to differentiatebetween acute hepatitis B and acute exacerbation ofchronic hepatitis B? Page:180—182
14. Regulated differentiation of stem cells into an artificial3D liver as a transplantable source Page:163—179
15. Switching to systemic therapy after locoregionaltreatment failure: Definition and best timing Page:155—162
16. Drug induced liver injury: East versus West– a systematic review and meta-analysis Page:142—154
17. Application of transient elastography in nonalcoholicfatty liver disease Page:128—141
18. KASL clinical practice guidelines for liver cirrhosis:Varices, hepatic encephalopathy, and relatedcomplications Page:83—127